Category archives for: Consumer

Cardiome Pharma hitting resistance at $9.00

Before you commit new money to your existing position in COM let it make a sustained break above $9.00 and watch for continued support at $8.00 so that you hold onto the profits you have already earned.

Mind the gap

As far as your question of pumping and dumping in the stock I can’t say but its clear that there are a number of other issues that need to be recognized and managed if you are going to hunt in this gap.

A perscription for losses

At this point I would suggest that anticipating a bottom is where we get into trouble

FXA has caught a cold

I think that the market has the story on FXA. It’s a stock that has enjoyed a nice run but investors are not convinced that it can maintain the sales increases that are seen to driven by one time events.

Maybe but not now

Currently the stock is trading below the 50 and 200 day moving averages and is currently in a downtrend.

Profits at anchor

Until there is mounting evidence that the consumer has the confidence needed to go out an buy apleasure craft and that operators are willing to spruce up their facilities, investors may have to live off the seven bagger BC has already brought to the party.

Not so nu

NCS has developed wound dressings that are coated with nanoparticles of silver to accelerate the healing process.

Content © Relentless Economics - Charts courtesy Stockcharts.com - Employees Entrance